Joinn Laboratories(China)Co.,Ltd. (HKG:6127)

Market Cap	26.09B
Revenue (ttm)	2.12B
Net Income (ttm)	415.38M
Shares Out	n/a
EPS (ttm)	0.55
PE Ratio	62.81
Forward PE	139.49
Dividend	0.00 (0.01%)
Ex-Dividend Date	Jun 26, 2025

Volume	6,914,871
Average Volume	8,813,372
Open	24.94
Previous Close	24.94
Day's Range	24.00 - 25.04
52-Week Range	6.31 - 28.70
Beta	0.86
RSI	59.60
Earnings Date	Aug 27, 2025

About HKG:6127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1995
• Employees: 2,652
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6127

Financial Performance

In 2024, HKG:6127's revenue was 2.02 billion, a decrease of -15.07% compared to the previous year's 2.38 billion. Earnings were 74.08 million, a decrease of -81.34%.

Financial numbers in CNY